Diabetes drug could help those living with Parkinson's disease, research reveals

Study suggests that exenatide, currently used to treat type 2 diabetes, improves movement-related issues and might also slow the progression of the disease

A drug commonly used to treat diabetes could help those living with Parkinson's disease, research has revealed.

By 2020 it is predicted that 162,000 individuals in the UK will be living with the condition. While existing drugs help to control its symptoms, there are currently none available which slow or halt its progression.